Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-31

Clinical Trial Update: Impella Reverse Remodeling in End-Stage Heart Failure

View source ↗

Summary

This clinical trial is recruiting to evaluate the Impella heart pump's ability to reverse remodeling in end-stage heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Impella (Impella microaxial pump)

Snippet

Sponsor: Columbia University | Conditions: Heart Failure, Cardiomyopathy | Status: RECRUITING